Comparisons of QTd and QTcD and Arrhythmia Prevalence Between Fibrinolytic Therapy and Primary Percutaneous Coronary Intervention

Document Type : Original Article


1 Atherosclerosis Prevention Research Center, Imam Reza Educational Hospital, Mashhad University of Medical Sciences (MUMS), Mashhad, IR Iran.

2 Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran.


Background: The inter-lead variations in the measurements of the QT interval reflect regional variations in ventricular repolarization. This increased dispersion results in susceptibility to ventricular arrhythmias.
Methods: We reviewed the medical records of 60 patients with ST-segment-elevation myocardial infarction (STEMI) over the last 6 years who received thrombolytic therapy (30 cases) or underwent primary percutaneous coronary intervention (PCI) (30 cases) in Ghaem Hospital and Emam Reza Hospital in Mashhad, Iran. The patients’ demographic characteristics, risk factors, treatment success, QTd and QTcD before and 24 hours after treatment, arrhythmias, and echocardiographic information were analyzed. Statistical analysis was conducted using the SPSS software, version 22, and a P value of less than 0.05 was considered statistically significant.
Results: The success rates (50% reduction in ST-segment elevation) of primary PCI and thrombolytic therapy were 66.66% and 33.33%, respectively. In addition, QTd and QTcD were significantly decreased in both successful procedures (P = 0.04 and 0.03, respectively). However, no significant difference in the variations of QTd and QTcD was seen between the 2 successful procedures (P = 0.91 and P = 0.87, respectively). Further, ventricular arrhythmias were evident in 36.6% of the patients with thrombolytic therapy, but no ventricular arrhythmia was observed in those who underwent primary PCI.
Conclusions: QTd and QTcD were identified as useful predictors of ventricular arrhythmias. A significant reduction in QTd and QTcD in both successful procedures was evident, leading to a decrease in ventricular arrhythmias. Moreover, the success rate of primary PCI was higher than that of thrombolytic therapy. Therefore, primary PCI was identified as a more appropriate procedure for STEMI. (Iranian Heart Journal 2020; 21(3): 15-24)


  1. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362:2155–2165.
  2. Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, Murray CJL, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015; 132:1667–1678.
  3. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update. A report from the American Heart Association. Circulation. 2017; 135(10):e146–e603.
  4. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127:e362.
  5. Jollis JG, Granger CB, Henry TD, Antman EM, Berger PB, Moyer PH, et al. Systems of care for ST-segment-elevation myocardial infarction: a report from the American Heart Association's Mission: Lifeline. Circ Cardiovasc Qual Outcomes. 2012; 5(4):423–428
  6. Nguyen HL, Saczynski JS, Gore JM, Goldberg RJ, et al. Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes. 2010; 3(1):82–92.
  7. Patel M, Dunford JV, Aguilar S, Castillo E, Patel E, Fisher R, Ochs G, Mahmud E, et al. Pre-hospital electrocardiography by emergency medical personnel: effects on scene and transport times for chest pain and STsegment elevation myocardial infarction patients. J Am Coll Cardiol. 2012; 60(9):806–811.
  8. Zipes DP, Calkins H, Daubert JP, Ellenbogen KA, Field ME, Fisher JD, et al. 2015 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology (a revision of the ACC/AHA 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion). J Am Coll Cardiol. 2015; 66(24):2767–2802.
  9. Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PL, et al. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation. 1996; 94(5):1147–1166.
  10. Epstein AE, Baessler CA, Curtis AB, Estes NA 3rd, Gersh BJ, Grubb B, et al. Addendum to “Personal and public safety issues related to arrhythmias that may affect consciousness”: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. “Public safety issues in patients with implantable defibrillators”: a scientific statement from the American Heart Association and the Heart Rhythm Society. Heart Rhythm. 2007; 4(3):386–393.
  11. Nikiforos S, Hatzisavvas J, Pavlides G, Voudris V, Vassilikos VP, Manginas A. QT-interval dispersion in acute myocardial infarction is only shortened by thrombolysis in myocardial infarction grade 2/3 reperfusion. Clin Cardiol. 2003; 26(6):291-5.
  12. Ilkay E, Yavuzkir M, Karaca I, Akbulut M, Pekdemir M, Aslan N. The effect of ST resolution on QT dispersion after interventional treatment in acute myocardial infarction. Clin Cardiol. 2004; 27(3):159-62.
  13. Lopes NH, Grupi C, Dina CH, de Gois AF, Hajjar LA, Ayub B, et al. QT interval dispersion analysis in acute myocardial infarction patients: coronary reperfusion effect. Arq Bras Cardiol. 2006; 87(2):91-8.
  14. Nikiforos S1, Hatzisavvas J, Pavlides G, Voudris V, Vassilikos VP, Manginas A, Hatzeioakim G, Foussas S, Iliodromitis EK, Hatseras D, Kremastinos DT, Cokkinos DV. QT-interval dispersion in acute myocardial infarction is only shortened by thrombolysis in myocardial infarction grade 2/3 reperfusion. Clin Cardiol. 2003 Jun; 26(6):291-5.
  15. Wahab A1, Zaheer MS, Rabbani MU, Wahab S. A study of heart rate variability and QT dispersion in patients of acute ST elevation myocardial infarction. Indian Heart J. 2009 May-Jun; 61(3):261-4.
  16. Bonakdar HR1, Aslanpour M1, Moladoust H2, Sadeghipour P1, Mohamadi F3, Rad MA1, Kheirkhah J1. Comparison between QT Interval Parameters in Type 2 Diabetic and Nondiabetic Patients with Non-ST Elevation Myocardial Infarction. J Tehran Heart Cent. 2014;9(4):166-73. Epub 2014 Jul 6.
  17. Jiménez-Candil J1, Hernández Hernández J, Aguero VL, Martín A, Martín F, Moríñigo JL, Martín-Luengo C. Early reduction of QT dispersion after primary percutaneous intervention in ST-segment elevation acute myocardial infarction. Mechanisms and clinical implications. Cardiology. 2009; 113(3):172-9. doi:10.1159/000189791. Epub 2009 Jan 9.
  18. Lancellotti P1, Mipinda JB, Pierard LA. Electrocardiographic changes during dobutamine stress testing in patients with recent myocardial infarction: relation with residual infarct artery stenosis and contractile recovery. Acta Cardiol. 2004 Feb; 59(1):11-6.
  19. Eslami V1, Safi M, Taherkhani M, Adibi A, Movahed MR. Evaluation of QT, QT dispersion, and T-wave peak to end time changes after primary percutaneous coronary intervention in patients presenting with acute ST-elevation myocardial infarction. J Invasive Cardiol. 2013 May; 25(5):232-4.
  20. Pan KL1, Hsu JT, Chang ST, Chung CM, Chen MC. Prognostic value of QT dispersion change following primary percutaneous coronary intervention in acute ST elevation myocardial infarction. Int Heart J. 2011;52(4):207-11
  21. Chávez-González E1, Rodríguez Jiménez AE2, Moreno-Martínez FL3. QRS duration and dispersion for predicting ventricular arrhythmias in early stage of acute myocardial infraction. Med Intensiva. 2017 Aug - Sep; 41(6):347-355. doi:10.1016/j.medin.2016.09.008. Epub 2017 Mar 9.
  22. Oni Heris S1, Rahimi B2, Faridaalaee G3, Hajahmadi M2, Sayyadi H4, Naghipour B5. QT Dispersion after Thrombolytic Therapy. Int Cardiovasc Res J. 2014 Dec; 8(4):161-5. Epub 2014 Dec 1.
  23. Aziz F1, Doddi S, Alok A, Penupolu S, Singh V, Benz M, Abed M. QT dispersion as a predictor for arrhythmias in patients with acute ST elevation myocardial infarction. J Thorac Dis. 2010 Jun; 2(2):86-8.
  24. Dotta G1, Fonseca FAH1, Izar MCO1, Souza MT1, Moreira FT1, Pinheiro LFM1, Barbosa AHP1, Caixeta AM1, Póvoa RMS1, Carvalho AC1, Bianco HT1. Regional QT Interval Dispersion as an Early Predictor of Reperfusion in Patients with Acute Myocardial Infarction after Fibrinolytic Therapy. Arq Bras Cardiol. 2018 Dec 17. pii:S0066-782X2018005019101. doi:10.5935/abc.20180239. [Epub ahead of print].
  25. Rahimi Darabad B1, Vatandust J, Pourmousavi Khoshknab MM, Seyed Mohammad Zad MH. Survey of the effect of streptokinase on ventricular repolarization by examining the QT dispersion in patients with acute myocardial infraction in Seyed-Al-Shohada hospital, Urmia. Glob J Health Sci. 2014 Sep 18; 6(7 Spec No):74-82. doi: 10.5539/gjhs.v6n7p74